ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2009

Mar 11, 2009

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LTD ABN 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR ROBERT BARTLETT ELLIOTT
Date of last notice	21 JANUARY 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this in		cludes interests in the trust made available by the responsible entity of the t“			rust”
Note: In the case of a company,		interests which come within paragraph (i) of the definition of notifiable interest of a			director should be
disclosed in this part.Direct or indirect inteNature of indirect inte
	Direct or indirect inte	rest	DIRECT
	Nature of indirect inte	rest
	(including registeredNote: Provide details of theinterest.	holder)circumstances giving rise to the relevant
	Date of change		11 MARCH 2009
	No. of securities held	prior to change	2,567,126 ORDINARYROBERT BARTLETT E537500 OPTIONS –		SHARES (HELDLLIOTT)CLASS A EXPIR
	Class		ORDINARY SHARE	S
	Number acquired		26,000

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number disposed	NIL
Value/Consideration	$0.09 EACH SHARE
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	2,593,126 ORDINARY SHARES (HELD BY
	ROBERT BARTLETT ELLIOTT)
	537,500 OPTIONS – CLASS A EXPIRING
	30/06/2010
	1,485,800 OPTIONS – CLASS B EXPIRING
	30/06/2010
	350,000 OPTIONS - EXERCISABLE AT
	$0.30 PER SHARE, VESTING ON 9 MARCH
	2007 AND EXPIRING ON 9 MARCH 2009
	104,166 ORDINARY SHARES (HELD BY
	PANCELL LIMITED)
Nature of change	ON MARKET TRADE
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002